Full-Time

Hospital Complex Wound Specialist

Smith+Nephew

Smith+Nephew

10,001+ employees

Global medical devices for orthopedics

No salary listed

Leicester, UK + 4 more

More locations: Oxford, UK | Reading, UK | Watford, UK | Welwyn Garden City, UK

Hybrid

Hybrid role; some on-site presence may be required.

Category
Medical, Clinical & Veterinary (1)

Get referred to Smith+Nephew

Find people who can refer or advise you

Requirements
  • Are a Registered General Nurse or from a profession allied to medicine, with strong clinical aptitude and a passion for improving patient care
  • Bring experience in wound care and especially NPWT, plus a solid understanding of NHS pathways and decision-making processes
  • Have excellent communication and organisational skills to deliver impactful training, manage priorities and build strong relationships
  • Are comfortable travelling extensively across your territory and engaging with stakeholders at all levels to drive adoption of advanced therapies
Responsibilities
  • You’ll be the trusted clinical expert that clinicians turn to for guidance on NPWT and advanced wound management.
  • In this role, you’ll work across acute, delivering hands-on clinical support and education that makes a real difference to patient care.
  • You’ll design and deliver high-quality NPWT (Negative Pressure Wound Therapy) training programmes, support complex wound cases, and demonstrate the clinical benefits of our PICO and Renasys systems.
  • Beyond clinical support, you’ll collaborate with territory managers and account teams to implement strategic projects, influence key decision makers, and lead initiatives that improve clinical outcomes and efficiency.
  • Every day will bring variety, from advising Tissue Viability Nurses and Theatre teams to partnering on audits and clinical pathways that shape best practice.

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Get referred to Smith+Nephew

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent launches drove over 60% of 2025 growth.
  • LEAF and RENASYS EDGE emphasize measurable workflow savings for hospitals.
  • Integrity Orthopaedics and Atracsys expand sports medicine and digital surgery capabilities.

What critics are saying

  • China pricing reforms compress orthopaedics and wound-care margins.
  • US reimbursement changes threaten robotics and implant adoption.
  • CORI XT faces entrenched competitors and a still-thin installed base.

What makes Smith+Nephew unique

  • Smith+Nephew spans orthopaedics, sports medicine, and advanced wound care globally.
  • CORI XT extends handheld robotics from knees into shoulders and hips.
  • Its portfolio combines devices, digital planning, navigation, and wound-monitoring software.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Parental Leave

Fertility Treatment Support

Family Planning Benefits

Tuition Reimbursement

Wellness Program

Mental Health Support

Volunteer Time Off

Home Office Stipend

Phone/Internet Stipend

Discounted Stock Options

Health Savings Account/Flexible Spending Account

Employee Assistance Program

PTO/vacation?

Paid Sick Leave

Company News

Yahoo Finance
Mar 4th, 2026
Smith & Nephew reports $6.2B revenue with 5.3% growth and 53% jump in free cash flow

Smith & Nephew reported strong full-year 2025 results, with revenue of $6.2 billion representing 5.3% underlying growth and 6.1% reported growth. Fourth-quarter revenue reached $1.7 billion, growing 6.2% on an underlying basis. The medical device company achieved 160 basis points of margin expansion, with trading profit of $1.2 billion and adjusted earnings per share of $1.02, up 21%. Free cash flow increased 52.5% year-on-year to $840 million, enabling completion of a $500 million share buyback programme. Innovation drove over 60% of growth, with products launched in the past five years delivering double-digit growth across all business units. For 2026, the company expects 6% organic revenue growth and 8% trading profit growth to around $1.3 billion, though it faces headwinds from Chinese pricing reforms and US reimbursement changes.

Yahoo Finance
Feb 25th, 2026
Smith & Nephew signs exclusive US distribution deal with RMR Ortho for A'TOMIC Nitinol Fixation System

Smith+Nephew has signed an exclusive US distribution agreement with RMR Ortho to add the A'TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle and Hand & Wrist portfolio. The partnership enables Smith+Nephew to expand its participation in high-frequency fracture and arthrodesis procedures whilst utilising its existing Extremities and Trauma sales channel. The dynamic compression fixation solution complements the company's current technologies. Scott Gunn, Vice President of US Marketing at Smith+Nephew, said the collaboration reflects the company's disciplined approach to portfolio expansion and continued focus on driving sustainable growth.

Investegate Ltd
Jan 12th, 2026
Smith+Nephew acquires Integrity Orthopaedics for $225M plus $225M in performance payments

Smith+Nephew has acquired Integrity Orthopaedics for an initial $225 million cash payment, plus up to $225 million in performance-based payments over five years. The deal strengthens Smith+Nephew's sports medicine portfolio with the Tendon Seam rotator cuff repair technology. Founded in 2020, Integrity Orthopaedics developed the innovative system to address high failure rates in traditional rotator cuff repairs. The technology uses patented micro-anchors and continuous suture designed to deliver stronger repairs and lower re-tear rates. Early clinical results show reduced pain and shorter recovery times. The rotator cuff repair market performs approximately 500,000 procedures annually in the US, valued at $875 million. The acquisition, expected to close by end of January 2026, will be financed from existing cash facilities and is expected to be accretive to trading profit margin by 2028.

Startupticker.ch
Jun 2nd, 2025
Smith & Nephew acquires Atracsys to expand its digital surgery ecosystem

Download the Swiss reference publication on investments, investors and exits in our assets section.

The Manila Times
Mar 11th, 2025
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for robotics, knees, hips, and shoulders at AAOS 2025.